Identification | Back Directory | [Name]
3-[5-[(E)-(carbamothioylhydrazinylidene)methyl]furan-2-yl]benzoic acid | [CAS]
301347-96-6 | [Synonyms]
F8-S40 3-[5-[(E)-(carbamothioylhydrazinylidene)methyl]furan-2-yl]benzoic acid Benzoic acid, 3-[5-[[2-(aminothioxomethyl)hydrazinylidene]methyl]-2-furanyl]- | [Molecular Formula]
C13H11N3O3S | [MOL File]
301347-96-6.mol | [Molecular Weight]
289.31 |
Hazard Information | Back Directory | [Uses]
F8-S40 is an inhibitor of SARS-CoV-2 main protease, with an IC50 of 10.88 μM[1]. | [References]
[1] Dou X, et, al. Discovery of 2-(furan-2-ylmethylene)hydrazine-1-carbothioamide derivatives as novel inhibitors of SARS-CoV-2 main protease. Eur J Med Chem. 2022 Aug 5;238:114508. DOI:10.1016/j.ejmech.2022.114508 |
|
Company Name: |
PHARMEKS Ltd.
|
Tel: |
+7 (495) 702-9648 |
Website: |
www.pharmeks.com |
|